Crystal R. Waites

Urothelial Carcinogenesis in the Urinary Bladder of Male Rats Treated with Muraglitazar, a PPARα/γ Agonist: Evidence for Urolithiasis as the Inciting Event in the Mode of Action

Mark A. Dominick, Melvin R. White, Thomas P. Sanderson et al. · Toxicologic Pathology · 2006 · 92 citations · Full text

Molecular Pharmacology, Urological Research, Urology +14

Evidence of foam cell and cholesterol crystal formation in macrophages incubated with oxidized LDL by fluorescence and electron microscopy.

A M Klinkner, Crystal R. Waites, William Kerns et al. · Journal of Histochemistry & Cytochemistry · 1995 · 66 citations · Full text

Immunology, Cellular Physiology, Oxidative Stress +19

Rodent Carcinogenicity Profile of the Antidiabetic Dual PPAR α and γ Agonist Muraglitazar

Sarah H. Tannehill‐Gregg, Thomas P. Sanderson, Daniel J. Minnema et al. · Toxicological Sciences · 2007 · 51 citations

Molecular Pharmacology, Urology, Oncology +15

Nonclinical Safety Evaluation of Muraglitazar, a Novel PPARα/γ Agonist

Crystal R. Waites, Mark A. Dominick, Thomas P. Sanderson et al. · Toxicological Sciences · 2007 · 41 citations · Full text

A Novel Technique For Mapping the Lipid Composition of Atherosclerotic Fatty Streaks by En Face Fluorescence Microscopy

Anne M. Klinkner, Peter J. Bugelski, Crystal R. Waites et al. · Journal of Histochemistry & Cytochemistry · 1997 · 36 citations

Lipid Analysis, Pathology, Lipid Movement +20